Delivery Order SPE2DB24D2003-SPE2DB25FXLJ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency awarded a $1,871.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,446.40. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This award carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7K to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,549.80 on July 29, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.24 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60 count). This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The contractor will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where it maintains operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8.76K to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award is structured as a child contract under a larger indefinite delivery vehicle, leveraging the company's established...
- The Defense Logistics Agency awarded a $1,866.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, with an ultimate completion date of July 24, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This award involved no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Multaq 400 mg tablets in a quantity of 60 units, valued at $24,080.88 under a firm fixed-price contract. This is a non-set-aside award, meaning it was competitively procured and open to all qualified vendors. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLJ3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $4,435.36. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The contract is scheduled for ultimate completion on August 6, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is a prescription antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the Defense Logistics Agency's responsibility for supplying pharmaceutical products to support military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to deliver a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued award of delivery orders under this IDC demonstrates its established capability to meet federal procurement requirements through open competition and its significant role as a major pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/5/25 |